Target Groups for Preventing AIDS Among Intravenous Drug Users: 2. The "Hard" Data Studies

Don Des Jarlais, Samuel R. Friedman, Cathy Casriel

Research output: Contribution to journalArticle

Abstract

Studies were reviewed with respect to three different target groups for preventing AIDS among intravenous (IV) drug users by (a) providing drug abuse treatment for those who want to stop injecting drugs, (b) providing "safer" injection for those who are likely to continue injecting, and (c) preventing drug injection among those who are at high risk for beginning to inject. The studies reviewed were limited to those that include "hard" data: validated self-reports, seroprevalence outcomes, or self-reports of behavior that is the opposed to any of the demand characteristics generated by the research setting. For two groups of current IV drug users-those entering drug treatment and those continuing to inject-these hard data studies show rapidly induced AIDS risk reduction but suggest a need for large-scale change maintained over long time periods. In terms of preventing initial injection, alternative forms of intense drug use have emerged but have not supplanted drug injection, and basic knowledge of AIDS does not appear to deter initial drug injection.

Original languageEnglish (US)
Pages (from-to)50-56
Number of pages7
JournalJournal of Consulting and Clinical Psychology
Volume58
Issue number1
DOIs
StatePublished - Jan 1 1990

Fingerprint

Drug Users
Acquired Immunodeficiency Syndrome
Injections
Pharmaceutical Preparations
Self Report
Seroepidemiologic Studies
Risk Reduction Behavior
Substance-Related Disorders
Therapeutics
Research

ASJC Scopus subject areas

  • Clinical Psychology
  • Psychiatry and Mental health

Cite this

Target Groups for Preventing AIDS Among Intravenous Drug Users : 2. The "Hard" Data Studies. / Des Jarlais, Don; Friedman, Samuel R.; Casriel, Cathy.

In: Journal of Consulting and Clinical Psychology, Vol. 58, No. 1, 01.01.1990, p. 50-56.

Research output: Contribution to journalArticle

@article{3ffc9b7098ea4f30a0b19d009ffd5d29,
title = "Target Groups for Preventing AIDS Among Intravenous Drug Users: 2. The {"}Hard{"} Data Studies",
abstract = "Studies were reviewed with respect to three different target groups for preventing AIDS among intravenous (IV) drug users by (a) providing drug abuse treatment for those who want to stop injecting drugs, (b) providing {"}safer{"} injection for those who are likely to continue injecting, and (c) preventing drug injection among those who are at high risk for beginning to inject. The studies reviewed were limited to those that include {"}hard{"} data: validated self-reports, seroprevalence outcomes, or self-reports of behavior that is the opposed to any of the demand characteristics generated by the research setting. For two groups of current IV drug users-those entering drug treatment and those continuing to inject-these hard data studies show rapidly induced AIDS risk reduction but suggest a need for large-scale change maintained over long time periods. In terms of preventing initial injection, alternative forms of intense drug use have emerged but have not supplanted drug injection, and basic knowledge of AIDS does not appear to deter initial drug injection.",
author = "{Des Jarlais}, Don and Friedman, {Samuel R.} and Cathy Casriel",
year = "1990",
month = "1",
day = "1",
doi = "10.1037/0022-006X.58.1.50",
language = "English (US)",
volume = "58",
pages = "50--56",
journal = "Journal of Consulting and Clinical Psychology",
issn = "0022-006X",
publisher = "American Psychological Association Inc.",
number = "1",

}

TY - JOUR

T1 - Target Groups for Preventing AIDS Among Intravenous Drug Users

T2 - 2. The "Hard" Data Studies

AU - Des Jarlais, Don

AU - Friedman, Samuel R.

AU - Casriel, Cathy

PY - 1990/1/1

Y1 - 1990/1/1

N2 - Studies were reviewed with respect to three different target groups for preventing AIDS among intravenous (IV) drug users by (a) providing drug abuse treatment for those who want to stop injecting drugs, (b) providing "safer" injection for those who are likely to continue injecting, and (c) preventing drug injection among those who are at high risk for beginning to inject. The studies reviewed were limited to those that include "hard" data: validated self-reports, seroprevalence outcomes, or self-reports of behavior that is the opposed to any of the demand characteristics generated by the research setting. For two groups of current IV drug users-those entering drug treatment and those continuing to inject-these hard data studies show rapidly induced AIDS risk reduction but suggest a need for large-scale change maintained over long time periods. In terms of preventing initial injection, alternative forms of intense drug use have emerged but have not supplanted drug injection, and basic knowledge of AIDS does not appear to deter initial drug injection.

AB - Studies were reviewed with respect to three different target groups for preventing AIDS among intravenous (IV) drug users by (a) providing drug abuse treatment for those who want to stop injecting drugs, (b) providing "safer" injection for those who are likely to continue injecting, and (c) preventing drug injection among those who are at high risk for beginning to inject. The studies reviewed were limited to those that include "hard" data: validated self-reports, seroprevalence outcomes, or self-reports of behavior that is the opposed to any of the demand characteristics generated by the research setting. For two groups of current IV drug users-those entering drug treatment and those continuing to inject-these hard data studies show rapidly induced AIDS risk reduction but suggest a need for large-scale change maintained over long time periods. In terms of preventing initial injection, alternative forms of intense drug use have emerged but have not supplanted drug injection, and basic knowledge of AIDS does not appear to deter initial drug injection.

UR - http://www.scopus.com/inward/record.url?scp=0025075087&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025075087&partnerID=8YFLogxK

U2 - 10.1037/0022-006X.58.1.50

DO - 10.1037/0022-006X.58.1.50

M3 - Article

C2 - 2181005

AN - SCOPUS:0025075087

VL - 58

SP - 50

EP - 56

JO - Journal of Consulting and Clinical Psychology

JF - Journal of Consulting and Clinical Psychology

SN - 0022-006X

IS - 1

ER -